GLP-1 medication used in the polyendocrine metabolic ovarian syndrome trial Friday, July 10, 2026 in Aurora, Colo. (AP Photo/Brittany Peterson)
Photos
News Sections
In Other News
- U.S: Rescuers saved some 80 people in Grand Canyon floods that left 2 dead and 1 missing, officials say
- World: Mass burials in Nepal as death toll from flash floods exceeds 1,000
- Politics: Macho, macho men? Democrats talk masculinity on campaign trail after years of Trump's bravado
- Sports: Aaron Donald follows other Hall of Fame-caliber athletes in his return from retirement
- Showbiz: Aaron Sorkin hits refresh on Facebook in 'The Social Reckoning' — Fall Movie Preview
- Money: Stocks slip on Wall Street under pressure from rising oil prices, bond sell-off
- Tech: Aaron Sorkin hits refresh on Facebook in 'The Social Reckoning' — Fall Movie Preview
- Science: Nepal floods expose risks to hydropower in a warming Himalayas
- Health: Congo authorities report more than 6,000 confirmed Ebola cases and nearly 3,000 deaths